Ignite Creation Date:
2024-05-06 @ 3:22 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04609046
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2020-10-29
Brief Title:
Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System |
Keywords: